Precision medicine in Type 2 Diabetes.

Main|Search|PHGKB






Last Posted: Nov 15, 2018

---

• Precision medicine in Type 2 Diabetes.
  Prasad Rashmi B et al. Journal of internal medicine 2018 Nov
• South African dyslipidaemia guideline consensus statement: 2018 update A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA).
  Klug E et al. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2018 Oct 108(11b) 973-1000
• Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis.
  Kishore Amit et al. Frontiers in genetics 2018 9503
• The National Diabetes Prevention Program — Changing Lifestyles to Prevent Type 2 Diabetes
  CDC Grand Rounds, November 13, 2018, 1pm ET
• Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping.
  Bale Bradley F et al. Frontiers in cardiovascular medicine 2018 5141
• Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications.
  Johns Emma C et al. Trends in endocrinology and metabolism: TEM 2018 Nov (11) 743-754
• Molecular Biomarkers for Gestational Diabetes Mellitus.
  Dias Stephanie et al. International journal of molecular sciences 2018 Sep (10)
• Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial.
  Kleinberger Jeffrey W et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 20(6) 583-590
• A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy.
  Grubb Anita L et al. Diabetes care 2018 Oct
• Generalizing polygenic risk scores from Europeans to Hispanics/Latinos.
  Grinde Kelsey E et al. Genetic epidemiology 2018 Oct

more